Detailed answers about THERACRYF PHARMA LTD, including incorporation, status, business activity, and accounts information.
When was THERACRYF PHARMA LTD founded?
THERACRYF PHARMA LTD was officially incorporated on 18 October 2007 and is registered under company number 06403643. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THERACRYF PHARMA LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of THERACRYF PHARMA LTD?
THERACRYF PHARMA LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THERACRYF PHARMA LTD do?
THERACRYF PHARMA LTD operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is THERACRYF PHARMA LTD's registered address?
The registered office address of THERACRYF PHARMA LTD is ALDERLEY PARK, CONGLETON ROAD, NETHER ALDERLEY, CHESHIRE, UNITED KINGDOM, SK10 4TG. This is the official address filed with Companies House for legal and statutory correspondence.
Is THERACRYF PHARMA LTD financially stable?
The most recent accounts for THERACRYF PHARMA LTD were made up to 31 March 2025, filed as SMALL. Next accounts are due by 31 December 2026.
Has THERACRYF PHARMA LTD changed its name?
Yes, THERACRYF PHARMA LTD has had 4 previous names: THERACRYF LIMITED (changed 24 April 2024), EVGEN LIMITED (changed 15 March 2024), NUTRAPROJECTS LIMITED (changed 20 August 2008), CALLQUEST LIMITED (changed 28 November 2007).